Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lactococcus lactis in mice
Tatiana Takiishi(KU Leuven), Chantal Mathieu(KU Leuven), Sofie Robert(KU Leuven), Silvia Caluwaerts(ActoGeniX (Belgium)), Letizia Galleri(University of Siena), Hannelie Korf(KU Leuven), Mark A. Atkinson(University of Florida), Lothar Steidler(ActoGeniX (Belgium)), Francesco Dotta(University of Chieti-Pescara), Pieter Demetter(Université Libre de Bruxelles), Clive Wasserfall(University of Florida), Isabella Spagnuolo(University of Siena), Pieter Rottiers(Ghent University), Fabio Arturo Grieco(University of Siena), Karolien Van Huynegem(ActoGeniX (Belgium)), Tom L. Van Belle(KU Leuven), Conny Gysemans(Diabetes Australia)
Cited by 198
Related Papers
Type 1 diabetes
|The Lancet|2013|2.7k
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
|Diabetes Care|2022|1.9k
Type 1 diabetes: new perspectives on disease pathogenesis and treatment
|The Lancet|2001|1.5k
Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
|Diabetes Care|2015|1.2k
The Pathogenesis of Insulin-Dependent Diabetes Mellitus
|New England Journal of Medicine|1994|1.1k